Denali Therapeutics Reports First Quarter 2018 Financial Results
11 mai 2018 08h00 HE
|
Denali Therapeutics Inc.
SOUTH SAN FRANCISCO, Calif., May 11, 2018 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ:DNLI), a biopharmaceutical company developing a broad portfolio of therapeutic candidates for...
Denali Therapeutics and Lonza Pharma & Biotech Announce Exclusive Partnership to Develop and Produce Biologic Medicines
08 févr. 2018 09h00 HE
|
Denali Therapeutics Inc.; Lonza Pharma & Biotech
Partnership aims to develop drugs for neurodegenerative diseasesDenali will draw on Lonza’s expertise in developing and manufacturing complex biologic molecules BASEL, Switzerland and SOUTH SAN...
Denali Therapeutics Announces Pricing of Initial Public Offering
07 déc. 2017 19h08 HE
|
Denali Therapeutics Inc.
SOUTH SAN FRANCISCO, Calif., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ:DNLI) today announced the pricing of its initial public offering of 13,888,888 shares of its common...
DiamiR Announces Oral Presentation at AD/PD(TM) 2017
29 mars 2017 08h02 HE
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - March 29, 2017) - DiamiR, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, today announced that Samuil...
DiamiR to Present at the GTCbio Biomarker Summit 2017
20 mars 2017 08h02 HE
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - March 20, 2017) - DiamiR, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, today announced that Kira...
DiamiR Announces Oral Presentation at Biomarkers Summit 2016
18 mars 2016 08h02 HE
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - March 18, 2016) - DiamiR, LLC, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, announced today that...
Jackson Laboratory researchers discover mutation involved in neurodegeneration
06 oct. 2015 08h52 HE
|
The Jackson Laboratory
BAR HARBOR, Maine, Oct. 6, 2015 (GLOBE NEWSWIRE) -- A mutation that increases the level of a special class of sphingolipids—molecules important to cell structure and signaling—can lead to...
Vaccinex Announces the Publication of Data Demonstrating Preclinical Efficacy in an Animal Model of Huntington Disease
17 févr. 2015 11h05 HE
|
Vaccinex, Inc.
ROCHESTER, N.Y., Feb. 17, 2015 (GLOBE NEWSWIRE) -- Vaccinex, Inc., a clinical-stage immunotherapy company engaged in the discovery and development of therapeutic monoclonal antibodies, today announced...
DiamiR Announces Poster Presentation at the Clinical Trials on Alzheimer's Disease 2014
17 nov. 2014 08h02 HE
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - November 17, 2014) - DiamiR Biosciences, a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today that the company's...
DiamiR Announces Publication and Discusses Merits of Universal Screening Test Based on Organ-Enriched microRNA Signatures
03 nov. 2014 08h02 HE
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - November 03, 2014) - DiamiR Biosciences Corp., a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today the...